These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29470971)

  • 41. [Autologous serum in treatment of dry eye].
    Babić GS; Cekić S
    Med Pregl; 2012; 65(11-12):511-5. PubMed ID: 23297619
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tear function and ocular surface findings in premature and term babies.
    Dogru M; Karakaya H; Baykara M; Ozmen A; Koksal N; Goto E; Matsumoto Y; Kojima T; Shimazaki J; Tsubota K
    Ophthalmology; 2004 May; 111(5):901-5. PubMed ID: 15121366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Punctal occlusion for dry eye syndrome.
    Ervin AM; Law A; Pucker AD
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006775. PubMed ID: 28649802
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lifitegrast ophthalmic solution 5.0% for treatment of dry eye disease: results of the OPUS-1 phase 3 study.
    Sheppard JD; Torkildsen GL; Lonsdale JD; D'Ambrosio FA; McLaurin EB; Eiferman RA; Kennedy KS; Semba CP;
    Ophthalmology; 2014 Feb; 121(2):475-83. PubMed ID: 24289915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Autologous Serum Versus Preservative Free Artificial Tear in Patients with Dry Eyes Due to Systemic Isotretinoin Therapy.
    Yılmaz U; Küçük E; Koç Ç; Gökler E
    Curr Eye Res; 2017 Jun; 42(6):827-831. PubMed ID: 28139163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy of punctum plug treatment in short break-up time dry eye.
    Kaido M; Ishida R; Dogru M; Tamaoki T; Tsubota K
    Optom Vis Sci; 2008 Aug; 85(8):758-63. PubMed ID: 18677228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transplantation of autologous serum-derived cultivated corneal epithelial equivalents for the treatment of severe ocular surface disease.
    Nakamura T; Inatomi T; Sotozono C; Ang LP; Koizumi N; Yokoi N; Kinoshita S
    Ophthalmology; 2006 Oct; 113(10):1765-72. PubMed ID: 16905193
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment.
    Jirsova K; Brejchova K; Krabcova I; Filipec M; Al Fakih A; Palos M; Vesela V
    Curr Eye Res; 2014 Jan; 39(1):21-30. PubMed ID: 24074049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of autologous serum in ophthalmic practice].
    López-García JS; García-Lozano I; Rivas L; Martínez-Garchitorena J
    Arch Soc Esp Oftalmol; 2007 Jan; 82(1):9-20. PubMed ID: 17262232
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Symptomatic dry eye treatment with autologous platelet-rich plasma.
    Alio JL; Colecha JR; Pastor S; Rodriguez A; Artola A
    Ophthalmic Res; 2007; 39(3):124-9. PubMed ID: 17374962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome.
    Urzua CA; Vasquez DH; Huidobro A; Hernandez H; Alfaro J
    Curr Eye Res; 2012 Aug; 37(8):684-8. PubMed ID: 22670856
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lenses in Patients with Ocular Chronic Graft-versus-Host Disease.
    Theophanous C; Irvine JA; Parker P; Chiu GB
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2180-2184. PubMed ID: 26234721
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
    Wilson SE; Perry HD
    Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of autologous serum in the treatment of ocular surface disorders.
    Jeng BH
    Arch Ophthalmol; 2011 Dec; 129(12):1610-2. PubMed ID: 22159683
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical outcomes of repeat autologous cultivated limbal epithelial transplantation for ocular surface burns.
    Basu S; Ali H; Sangwan VS
    Am J Ophthalmol; 2012 Apr; 153(4):643-50, 650.e1-2. PubMed ID: 22265153
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autologous serum eye drops for the treatment of dry eye diseases.
    Kojima T; Higuchi A; Goto E; Matsumoto Y; Dogru M; Tsubota K
    Cornea; 2008 Sep; 27 Suppl 1():S25-30. PubMed ID: 18813071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized, Multicenter, Double-Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease.
    Kawakita T; Uchino M; Fukagawa K; Yoshino K; Shimazaki S; Toda I; Tanaka M; Arai H; Sakatani K; Hata S; Okano T; Tsubota K
    Sci Rep; 2016 Feb; 6():20855. PubMed ID: 26865350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical Manifestation and Risk Factors Associated With Remission in Patients With Filamentary Keratitis.
    Lee SM; Jun RM; Choi KR; Han KE
    Am J Ophthalmol; 2020 Oct; 218():78-83. PubMed ID: 32574776
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tacrolimus Eye Drops as Adjunct Therapy in Severe Corneal Endothelial Rejection Refractory to Corticosteroids.
    Ghaffari R; Ghassemi H; Zarei-Ghanavati M; Latifi G; Dehghani S; Haq Z; Djalilian AR
    Cornea; 2017 Oct; 36(10):1195-1199. PubMed ID: 28817391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Corneal melting after ocular surgery in patients with auto-immune disorders].
    van der Meulen IJ; van Rooij J; Hazes JW; van Cleynenbreugel H; Geerards AJ; Remeyer L
    Ned Tijdschr Geneeskd; 2007 Apr; 151(16):920-3. PubMed ID: 17500345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.